Stock data
IN8bio, Inc. (INAB)
IN8bio, Inc. (INAB) reported net income of -US$19.44M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$19.44M | -US$19.44M | — |
| 2024 | — | — | -US$30.44M | -US$30.44M | — |
| 2023 | — | — | -US$30.01M | -US$30.01M | — |
| 2022 | — | — | -US$28.52M | -US$28.52M | — |
| 2021 | — | — | -US$14.65M | -US$14.65M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$4.78M | — |
| 2026-03-31 | — | -US$5.09M | — |
| 2025-12-31 | — | -US$4.94M | — |
| 2025-09-30 | — | -US$3.85M | — |
| 2025-06-30 | — | -US$5.09M | — |
| 2025-03-31 | — | -US$5.55M | — |
| 2024-12-31 | — | -US$6.16M | — |
| 2024-09-30 | — | -US$7.09M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.